PRESCIENT THERAPEUTICS LIMITED - Announcements

Market Cap $31.40M Add to my watchlist

Healthcare Biotechnology

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.More

Announcements

Filter Results

All Price Sensitive Only

PTX	Despatch of Pro-rata Rights Issue Offer Documents-PTX.AX		06/06/16	217.72KB	Share
PTX	Replacement Entitlement Offer Prospectus-PTX.AX	PRICE SENSITIVE	03/06/16	1.14MB	Share
PTX	Rights Issue Update-PTX.AX		01/06/16	110.21KB	Share
PTX	Change in substantial holding-PTX.AX		26/05/16	221.26KB	Share
PTX	Tranche 1 Capital Raising Complete and Appendix 3B-PTX.AX		24/05/16	561.59KB	Share
PTX	Notice of General Meeting/Proxy Form-PTX.AX		23/05/16	895.38KB	Share
PTX	Letter to Optionholders-PTX.AX		18/05/16	193.59KB	Share
PTX	Letter to Ineligible shareholders-PTX.AX		18/05/16	195.06KB	Share
PTX	Letter to Eligible Shareholders-PTX.AX		18/05/16	211.88KB	Share
PTX	Appendix 3B-PTX.AX		18/05/16	208.58KB	Share
PTX	Offer Document-PTX.AX	PRICE SENSITIVE	18/05/16	4.24MB	Share
PTX	PTX Secures $7.0M Capital Raising-PTX.AX	PRICE SENSITIVE	18/05/16	137.01KB	Share
PTX	Trading Halt-PTX.AX	PRICE SENSITIVE	16/05/16	532KB	Share
PTX	March 2016 Appendix 4C - Quarterly-PTX.AX	PRICE SENSITIVE	21/04/16	391.12KB	Share
PTX	Investor Presentation - April 2016-PTX.AX		13/04/16	2.12MB	Share
PTX	RedChip Issues Research on Prescient Therapeutics		31/03/16	314.51KB	Share
PTX	Edison Investment Research Initiates Coverage		03/03/16	312.67KB	Share
PTX	PTX Featured on Bloomberg's - The Redchip Money Report		02/03/16	440.17KB	Share
PTX	Appendix 4D and Half Year Financial Report		17/02/16	657.34KB	Share
PTX	PTX-200 Breast Cancer Trial Progresses	PRICE SENSITIVE	17/02/16	128.83KB	Share
PTX	Steven Yatomi-Clarke Appointed CEO	PRICE SENSITIVE	15/02/16	265.75KB	Share
PTX	Appendix 3B		05/02/16	546.79KB	Share
PTX	December 2015 Appendix 4C - Quarterly	PRICE SENSITIVE	25/01/16	467.39KB	Share
PTX	PTX Presents at NobleCon12		21/01/16	189.12KB	Share
PTX	Response to ASX Price Query	PRICE SENSITIVE	19/01/16	671.55KB	Share
PTX	Yale Hematolgy Leader Joins PTX Scientific Advisory Board		14/01/16	203.08KB	Share
PTX	PTX to present at Biotech Showcase 2016 in San Francisco		11/01/16	2.29MB	Share
PTX	FDA Allows PTX IND for Leukemia Phase Ib & II Trials	PRICE SENSITIVE	08/01/16	332.21KB	Share
PTX	Appendix 3B - Release of securities from escrow		11/12/15	164.65KB	Share
PTX	Change of Director's Interest Notice		08/12/15	258.61KB	Share
PTX	Becoming a substantial holder		03/12/15	108.5KB	Share
PTX	Change in substantial holding		01/12/15	130.88KB	Share
PTX	Investor Presentation - December 2015		01/12/15	1.58MB	Share
PTX	Section 708A Cleansing Notice and Appendix 3B		30/11/15	400.95KB	Share
PTX	H. Lee Moffitt Cancer Center Leukaemia Oncologist Joins SAB		30/11/15	324.54KB	Share
PTX	MD Anderson Leukaemia Expert Joins PTX SAB		26/11/15	335.18KB	Share
PTX	Change in substantial holding		25/11/15	131.89KB	Share
PTX	Change of Director's Interest Notice x4		25/11/15	571.06KB	Share
PTX	Additional Placement Raises $1.0 million	PRICE SENSITIVE	25/11/15	126.81KB	Share
PTX	Share Purchase Plan Completion & Appendix 3B		23/11/15	858.99KB	Share
PTX	Release of Securities from Escrow		20/11/15	295.88KB	Share
PTX	Share Purchase Plan Results		18/11/15	118.85KB	Share
PTX	PTX Shareholder Newsletter		09/11/15	747.32KB	Share
PTX	Results of Meeting		04/11/15	347.56KB	Share
PTX	New Investor Presentation		04/11/15	2.42MB	Share
PTX	Share Purchase Plan - Documentation issued to shareholders		02/11/15	803.34KB	Share
PTX	September 2015 Appendix 4C - Quarterly	PRICE SENSITIVE	30/10/15	460.96KB	Share
PTX	Cleansing Notice - Share Purchase Plan		29/10/15	226.77KB	Share
PTX	Share Purchase Plan Offer Document		29/10/15	269.07KB	Share
PTX	SPP Fully Underwritten up to target amount of $1.03 million	PRICE SENSITIVE	29/10/15	278.96KB	Share
PTX	Trading Halt	PRICE SENSITIVE	28/10/15	554.76KB	Share
PTX	Final Director's Interest Notice		15/10/15	18.79KB	Share
PTX	Executive Management Change	PRICE SENSITIVE	15/10/15	108.29KB	Share
PTX	Notice of Annual General Meeting/Proxy Form		05/10/15	544.3KB	Share
PTX	CSO named among Top 20 Translational Researchers by Nature		01/09/15	344.49KB	Share
PTX	Two new Patents granted to Protect Lead Asset PTX-200	PRICE SENSITIVE	31/08/15	143.62KB	Share
PTX	2015 Corporate Governance Statement and Appendix 4G		28/08/15	602.15KB	Share
PTX	Prescient Appendix 4E and 2015 Annual Report	PRICE SENSITIVE	28/08/15	588.32KB	Share
PTX	PTX-200 Phase 1B/2 Clinical Trial Update	PRICE SENSITIVE	26/08/15	351.17KB	Share
PTX	Proposed Grant of Options to Non-Executive Directors	PRICE SENSITIVE	21/08/15	124.29KB	Share
PTX	Prescient Shareholder Newsletter		12/08/15	976.89KB	Share
PTX	June 2015 Appendix 4C - Quarterly	PRICE SENSITIVE	30/07/15	463.75KB	Share
PTX	IND for Phase 1b/2 Ovarian Cancer Trial Transferred to PTX	PRICE SENSITIVE	29/06/15	126.1KB	Share
PTX	Change in substantial holding		26/06/15	173.89KB	Share
PTX	Becoming a substantial holder		26/06/15	210.19KB	Share
PTX	Change of Director's Interest Notices x 2		26/06/15	432.59KB	Share
PTX	s708A Notice & Appendix 3B		23/06/15	996.21KB	Share
PTX	PTX Issues shares for Milestone 1 - Pathway Acquisition		23/06/15	342.95KB	Share
PTX	US FDA Reactivates PTX's IND for PTX-100 Breast Cancer Trial	PRICE SENSITIVE	10/06/15	145.57KB	Share
PTX	Appendix 3B		27/05/15	154.92KB	Share
PTX	Distinguished Moffitt Cancer Center Scientist Appointed CSO		26/05/15	145.93KB	Share
PTX	Edison Investment Research Initiates Coverage		30/04/15	336.58KB	Share
PTX	March 2015 Appendix 4C - Quarterly	PRICE SENSITIVE	29/04/15	434.22KB	Share
PTX	Prescient Appoints Chief Medical Officer		28/04/15	353.42KB	Share
PTX	Encouraging Pre-Clinical Data Presented at US Cancer Meeting	PRICE SENSITIVE	21/04/15	347.82KB	Share
PTX	Approval received to transfer IND Sponsorship for PTX-200	PRICE SENSITIVE	01/04/15	68.29KB	Share
PTX	Roth Conference Presentation		10/03/15	1.05MB	Share
PTX	PTX to Present at 27th Annual Roth Conference		03/03/15	67.24KB	Share
PTX	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	27/02/15	1.02MB	Share
PTX	Prescient Therapeutics Granted Key U.S. Patents	PRICE SENSITIVE	23/02/15	210.04KB	Share
PTX	PTX Acquires Worldwide License for Cancer Biomarker p27	PRICE SENSITIVE	09/02/15	74.34KB	Share
PTX	Change of Company Secretary and Registered Office		03/02/15	174.45KB	Share
PTX	Appendix 3Ys		30/01/15	663.85KB	Share
PTX	December 2014 Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	322.22KB	Share

PTX Despatch of Pro-rata Rights Issue Offer Documents-PTX.AX
06/06/16		217.72KB	Share
PTX Replacement Entitlement Offer Prospectus-PTX.AX
03/06/16	PRICE SENSITIVE	1.14MB	Share
PTX Rights Issue Update-PTX.AX
01/06/16		110.21KB	Share
PTX Change in substantial holding-PTX.AX
26/05/16		221.26KB	Share
PTX Tranche 1 Capital Raising Complete and Appendix 3B-PTX.AX
24/05/16		561.59KB	Share
PTX Notice of General Meeting/Proxy Form-PTX.AX
23/05/16		895.38KB	Share
PTX Letter to Optionholders-PTX.AX
18/05/16		193.59KB	Share
PTX Letter to Ineligible shareholders-PTX.AX
18/05/16		195.06KB	Share
PTX Letter to Eligible Shareholders-PTX.AX
18/05/16		211.88KB	Share
PTX Appendix 3B-PTX.AX
18/05/16		208.58KB	Share
PTX Offer Document-PTX.AX
18/05/16	PRICE SENSITIVE	4.24MB	Share
PTX PTX Secures $7.0M Capital Raising-PTX.AX
18/05/16	PRICE SENSITIVE	137.01KB	Share
PTX Trading Halt-PTX.AX
16/05/16	PRICE SENSITIVE	532KB	Share
PTX March 2016 Appendix 4C - Quarterly-PTX.AX
21/04/16	PRICE SENSITIVE	391.12KB	Share
PTX Investor Presentation - April 2016-PTX.AX
13/04/16		2.12MB	Share
PTX RedChip Issues Research on Prescient Therapeutics
31/03/16		314.51KB	Share
PTX Edison Investment Research Initiates Coverage
03/03/16		312.67KB	Share
PTX PTX Featured on Bloomberg's - The Redchip Money Report
02/03/16		440.17KB	Share
PTX Appendix 4D and Half Year Financial Report
17/02/16		657.34KB	Share
PTX PTX-200 Breast Cancer Trial Progresses
17/02/16	PRICE SENSITIVE	128.83KB	Share
PTX Steven Yatomi-Clarke Appointed CEO
15/02/16	PRICE SENSITIVE	265.75KB	Share
PTX Appendix 3B
05/02/16		546.79KB	Share
PTX December 2015 Appendix 4C - Quarterly
25/01/16	PRICE SENSITIVE	467.39KB	Share
PTX PTX Presents at NobleCon12
21/01/16		189.12KB	Share
PTX Response to ASX Price Query
19/01/16	PRICE SENSITIVE	671.55KB	Share
PTX Yale Hematolgy Leader Joins PTX Scientific Advisory Board
14/01/16		203.08KB	Share
PTX PTX to present at Biotech Showcase 2016 in San Francisco
11/01/16		2.29MB	Share
PTX FDA Allows PTX IND for Leukemia Phase Ib & II Trials
08/01/16	PRICE SENSITIVE	332.21KB	Share
PTX Appendix 3B - Release of securities from escrow
11/12/15		164.65KB	Share
PTX Change of Director's Interest Notice
08/12/15		258.61KB	Share
PTX Becoming a substantial holder
03/12/15		108.5KB	Share
PTX Change in substantial holding
01/12/15		130.88KB	Share
PTX Investor Presentation - December 2015
01/12/15		1.58MB	Share
PTX Section 708A Cleansing Notice and Appendix 3B
30/11/15		400.95KB	Share
PTX H. Lee Moffitt Cancer Center Leukaemia Oncologist Joins SAB
30/11/15		324.54KB	Share
PTX MD Anderson Leukaemia Expert Joins PTX SAB
26/11/15		335.18KB	Share
PTX Change in substantial holding
25/11/15		131.89KB	Share
PTX Change of Director's Interest Notice x4
25/11/15		571.06KB	Share
PTX Additional Placement Raises $1.0 million
25/11/15	PRICE SENSITIVE	126.81KB	Share
PTX Share Purchase Plan Completion & Appendix 3B
23/11/15		858.99KB	Share
PTX Release of Securities from Escrow
20/11/15		295.88KB	Share
PTX Share Purchase Plan Results
18/11/15		118.85KB	Share
PTX PTX Shareholder Newsletter
09/11/15		747.32KB	Share
PTX Results of Meeting
04/11/15		347.56KB	Share
PTX New Investor Presentation
04/11/15		2.42MB	Share
PTX Share Purchase Plan - Documentation issued to shareholders
02/11/15		803.34KB	Share
PTX September 2015 Appendix 4C - Quarterly
30/10/15	PRICE SENSITIVE	460.96KB	Share
PTX Cleansing Notice - Share Purchase Plan
29/10/15		226.77KB	Share
PTX Share Purchase Plan Offer Document
29/10/15		269.07KB	Share
PTX SPP Fully Underwritten up to target amount of $1.03 million
29/10/15	PRICE SENSITIVE	278.96KB	Share
PTX Trading Halt
28/10/15	PRICE SENSITIVE	554.76KB	Share
PTX Final Director's Interest Notice
15/10/15		18.79KB	Share
PTX Executive Management Change
15/10/15	PRICE SENSITIVE	108.29KB	Share
PTX Notice of Annual General Meeting/Proxy Form
05/10/15		544.3KB	Share
PTX CSO named among Top 20 Translational Researchers by Nature
01/09/15		344.49KB	Share
PTX Two new Patents granted to Protect Lead Asset PTX-200
31/08/15	PRICE SENSITIVE	143.62KB	Share
PTX 2015 Corporate Governance Statement and Appendix 4G
28/08/15		602.15KB	Share
PTX Prescient Appendix 4E and 2015 Annual Report
28/08/15	PRICE SENSITIVE	588.32KB	Share
PTX PTX-200 Phase 1B/2 Clinical Trial Update
26/08/15	PRICE SENSITIVE	351.17KB	Share
PTX Proposed Grant of Options to Non-Executive Directors
21/08/15	PRICE SENSITIVE	124.29KB	Share
PTX Prescient Shareholder Newsletter
12/08/15		976.89KB	Share
PTX June 2015 Appendix 4C - Quarterly
30/07/15	PRICE SENSITIVE	463.75KB	Share
PTX IND for Phase 1b/2 Ovarian Cancer Trial Transferred to PTX
29/06/15	PRICE SENSITIVE	126.1KB	Share
PTX Change in substantial holding
26/06/15		173.89KB	Share
PTX Becoming a substantial holder
26/06/15		210.19KB	Share
PTX Change of Director's Interest Notices x 2
26/06/15		432.59KB	Share
PTX s708A Notice & Appendix 3B
23/06/15		996.21KB	Share
PTX PTX Issues shares for Milestone 1 - Pathway Acquisition
23/06/15		342.95KB	Share
PTX US FDA Reactivates PTX's IND for PTX-100 Breast Cancer Trial
10/06/15	PRICE SENSITIVE	145.57KB	Share
PTX Appendix 3B
27/05/15		154.92KB	Share
PTX Distinguished Moffitt Cancer Center Scientist Appointed CSO
26/05/15		145.93KB	Share
PTX Edison Investment Research Initiates Coverage
30/04/15		336.58KB	Share
PTX March 2015 Appendix 4C - Quarterly
29/04/15	PRICE SENSITIVE	434.22KB	Share
PTX Prescient Appoints Chief Medical Officer
28/04/15		353.42KB	Share
PTX Encouraging Pre-Clinical Data Presented at US Cancer Meeting
21/04/15	PRICE SENSITIVE	347.82KB	Share
PTX Approval received to transfer IND Sponsorship for PTX-200
01/04/15	PRICE SENSITIVE	68.29KB	Share
PTX Roth Conference Presentation
10/03/15		1.05MB	Share
PTX PTX to Present at 27th Annual Roth Conference
03/03/15		67.24KB	Share
PTX Appendix 4D and Half Year Financial Report
27/02/15	PRICE SENSITIVE	1.02MB	Share
PTX Prescient Therapeutics Granted Key U.S. Patents
23/02/15	PRICE SENSITIVE	210.04KB	Share
PTX PTX Acquires Worldwide License for Cancer Biomarker p27
09/02/15	PRICE SENSITIVE	74.34KB	Share
PTX Change of Company Secretary and Registered Office
03/02/15		174.45KB	Share
PTX Appendix 3Ys
30/01/15		663.85KB	Share
PTX December 2014 Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	322.22KB	Share

REFRESH

First 2 3 4

(20min delay)
Last 3.9¢		Change -0.003(7.14%)		Mkt cap ! $31.40M

Open	High	Low	Value	Volume
4.0¢	4.1¢	3.9¢	$75.11K	1.897M

Buyers (Bids)

No.	Vol.	Price($)
2	355874	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	75	1

View Market Depth

No.	Vol.	Price($)
2	355874	0.039
6	700788	0.038
3	80513	0.037
4	399500	0.036
4	298576	0.035

Price($)	Vol.	No.
0.040	75	1
0.041	230198	2
0.042	350000	2
0.043	247971	2
0.044	100000	1

Last trade - 15.59pm 19/06/2024 (20 minute delay)


Last 4.0¢		Change -0.003 ( 2.44 %)
Open	High	Low	Volume
4.0¢	4.1¢	4.0¢	733248
Last updated 15.59pm 19/06/2024 ?

PTX (ASX) Chart

PRESCIENT THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories